Literature DB >> 13586229

[Histopathological changes of the islands of Langerhans and their importance in the problem of the pathogenesis of human diabetes].

W GEPTS.   

Abstract

Entities:  

Keywords:  DIABETES MELLITUS/etiology and pathogenesis; ISLANDS OF LANGERHANS/pathology

Mesh：

Year:  1958        PMID： 13586229

Source DB:  PubMed          Journal:  Endokrinologie        ISSN： 0013-7251


× No keyword cloud information.
  8 in total

1.  The cytological composition of the foetal endocrine pancreas in normal and pathological conditions.

Authors:  F A Van Assche; W Gepts
Journal:  Diabetologia       Date:  1971-12       Impact factor: 10.122

2.  Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells.

Authors:  P Westermark; C Wernstedt; E Wilander; D W Hayden; T D O'Brien; K H Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

3.  Cell populations in the endocrine pancreas of human neonates and infants.

Authors:  J Rahier; J Wallon; J C Henquin
Journal:  Diabetologia       Date:  1981-05       Impact factor: 10.122

4.  The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus.

Authors:  P Westermark; E Wilander
Journal:  Diabetologia       Date:  1978-11       Impact factor: 10.122

5.  Cellular composition of the human diabetic pancreas.

Authors:  J Rahier; R M Goebbels; J C Henquin
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

Review 6.  Amyloid in the islets of Langerhans: thoughts and some historical aspects.

Authors:  Per Westermark
Journal:  Ups J Med Sci       Date:  2011-05       Impact factor: 2.384

7.  Pancreatic alpha cell mass in European subjects with type 2 diabetes.

Authors:  J C Henquin; J Rahier
Journal:  Diabetologia       Date:  2011-04-05       Impact factor: 10.122

Review 8.  β-Cell failure in type 2 diabetes.

Authors:  Gil Leibowitz; Nurit Kaiser; Erol Cerasi
Journal:  J Diabetes Investig       Date:  2011-04-07       Impact factor: 4.232
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.